EP3052098
ENZALUTAMIDE IN COMBINATION WITH AFURESERTIB FOR THE TREATMENT OF PROSTATE CANCER
:
EP einkaleyfi: Þýðing ekki lögð inn:
1.10.2014:
2.12.2020:
14790344.7
:
30.9.2034
:
ENZALUTAMIDE IN COMBINATION WITH AFURESERTIB FOR THE TREATMENT OF PROSTATE CANCER
1.10.2014
2.12.2020
:
Novartis AG:
Lichtstrasse 35, 4056 Basel, CH
:
CORNFELD, Mark J.:
Collegeville, Pennsylvania 19426, US
:
KUMAR, Rakesh:
Collegeville, Pennsylvania 19426, US
:
MORRIS, Shannon Renae:
Research Triangle Park, North Carolina 27709, US
:
201361885053 P:
1.10.2013:
US
:
201461935404 P:
4.2.2014:
US
:
IB2014064997:
1.10.2014
:
A61K 31/4155, A61K 31/4166, A61K 45/06, A61K 31/58, A61P 35/00, A61P 35/02